Applications from Agilent Technologies - page 1
Open paper Automated Data-Driven Optimization of MRM Transitions and CollisionEnergies in LC–MS/MS
Automated Data-Driven Optimization of MRM Transitions and CollisionEnergies in LC–MS/MS
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Other
Open paper Characterizing the Poly(A) tail in mRNA using Ion-Pairing Reversed-Phase LC/MS (IPRP-LC/MS) and Deconvolution Tools
Characterizing the Poly(A) tail in mRNA using Ion-Pairing Reversed-Phase LC/MS (IPRP-LC/MS) and Deconvolution Tools
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Evaluation of a Consensus Based MS/MS Library Matching Algorithm and Integration into a Non-Targeted Software Platform for Increasing Exposome Coverage
Evaluation of a Consensus Based MS/MS Library Matching Algorithm and Integration into a Non-Targeted Software Platform for Increasing Exposome Coverage
LC/MS, LC/MS/MS, Software
Instrumentation
LC/MS, LC/MS/MS, Software
Manufacturer
Agilent Technologies
Industries
Environmental
Open paper HRMS QTOF-PRM (Parallel reaction Monitoring) for ultra-trace level quantification of N-Nitroso Moxifloxacin in API and Formulations.
HRMS QTOF-PRM (Parallel reaction Monitoring) for ultra-trace level quantification of N-Nitroso Moxifloxacin in API and Formulations.
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
Ultra-Trace Quantification of N-Nitroso-desmethyl-sumatriptan with Interference Resolution Using LC–TQ
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
Rapid LC-MS/MS compound method development and sample analysis for DMPK workflows
LC/MS, LC/MS/MS, LC/QQQ, Software
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ, Software
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper Qualitative and Quantitative Determination of Furanocoumarins in Citrus Oils by LC/TOF
Qualitative and Quantitative Determination of Furanocoumarins in Citrus Oils by LC/TOF
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies
Industries
Food & Agriculture
Open paper A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
A Holistic View of GLP 1R Agonist–Mediated Cellular Response Revealed Through Orthogonal Technologies
LC/MS, LC/MS/MS, LC/QQQ
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Open paper LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS Characterization of GLP-1 Receptor Agonist Oligomers and Other Elusive Impurities
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
